Coya Therapeutics (COYA) Competitors $6.59 +0.49 (+8.03%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock COYA vs. PRTC, KROS, ERAS, SANA, ZVRA, SNDL, ORKA, KMDA, RVNC, and TECXShould you be buying Coya Therapeutics stock or one of its competitors? The main competitors of Coya Therapeutics include PureTech Health (PRTC), Keros Therapeutics (KROS), Erasca (ERAS), Sana Biotechnology (SANA), Zevra Therapeutics (ZVRA), SNDL (SNDL), Oruka Therapeutics (ORKA), Kamada (KMDA), Revance Therapeutics (RVNC), and Tectonic Therapeutic (TECX). These companies are all part of the "pharmaceutical products" industry. Coya Therapeutics vs. PureTech Health Keros Therapeutics Erasca Sana Biotechnology Zevra Therapeutics SNDL Oruka Therapeutics Kamada Revance Therapeutics Tectonic Therapeutic PureTech Health (NASDAQ:PRTC) and Coya Therapeutics (NASDAQ:COYA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Which has better earnings and valuation, PRTC or COYA? Coya Therapeutics has higher revenue and earnings than PureTech Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPureTech Health$3.33M124.49-$65.70MN/AN/ACoya Therapeutics$3.55M31.01-$7.99M-$0.98-6.72 Does the media refer more to PRTC or COYA? In the previous week, Coya Therapeutics had 5 more articles in the media than PureTech Health. MarketBeat recorded 8 mentions for Coya Therapeutics and 3 mentions for PureTech Health. PureTech Health's average media sentiment score of 1.10 beat Coya Therapeutics' score of 0.81 indicating that PureTech Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PureTech Health 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Coya Therapeutics 3 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in PRTC or COYA? 0.0% of PureTech Health shares are owned by institutional investors. Comparatively, 39.8% of Coya Therapeutics shares are owned by institutional investors. 5.3% of PureTech Health shares are owned by insiders. Comparatively, 12.0% of Coya Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, PRTC or COYA? PureTech Health has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, Coya Therapeutics has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Is PRTC or COYA more profitable? PureTech Health's return on equity of 0.00% beat Coya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets PureTech HealthN/A N/A N/A Coya Therapeutics N/A -31.63%-27.76% Do analysts rate PRTC or COYA? PureTech Health presently has a consensus price target of $45.00, suggesting a potential upside of 160.72%. Coya Therapeutics has a consensus price target of $17.00, suggesting a potential upside of 157.97%. Given PureTech Health's stronger consensus rating and higher probable upside, research analysts clearly believe PureTech Health is more favorable than Coya Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PureTech Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Coya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in PRTC or COYA? Coya Therapeutics received 16 more outperform votes than PureTech Health when rated by MarketBeat users. Likewise, 96.15% of users gave Coya Therapeutics an outperform vote while only 45.00% of users gave PureTech Health an outperform vote. CompanyUnderperformOutperformPureTech HealthOutperform Votes945.00% Underperform Votes1155.00% Coya TherapeuticsOutperform Votes2596.15% Underperform Votes13.85% SummaryPureTech Health and Coya Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Coya Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for COYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart COYA vs. The Competition Export to ExcelMetricCoya TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$110.22M$6.89B$5.56B$7.83BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-10.147.4422.4818.48Price / Sales31.01242.70394.56103.59Price / CashN/A65.8538.1834.62Price / Book2.676.516.774.25Net Income-$7.99M$143.21M$3.22B$248.23M7 Day Performance0.92%1.98%1.48%0.89%1 Month Performance4.44%6.89%3.99%3.53%1 Year Performance-24.43%-2.52%16.15%5.08% Coya Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COYACoya Therapeutics2.0037 of 5 stars$6.59+8.0%$17.00+158.0%-27.2%$110.22M$3.55M-10.146Upcoming EarningsAnalyst ForecastNews CoveragePRTCPureTech Health2.1948 of 5 stars$17.12-0.1%$45.00+162.8%-38.1%$411.25M$3.33M0.00100News CoverageGap DownKROSKeros Therapeutics3.1014 of 5 stars$14.26+0.4%$40.33+182.8%-74.4%$405.30M$3.55M-2.74100Upcoming EarningsPositive NewsERASErasca2.9722 of 5 stars$1.40+0.7%$4.83+245.2%-27.4%$396.57MN/A-1.69120Analyst ForecastPositive NewsSANASana Biotechnology1.903 of 5 stars$1.76-0.6%$10.80+513.6%-78.9%$396.04MN/A-1.26380Upcoming EarningsZVRAZevra Therapeutics2.7655 of 5 stars$7.20flat$22.29+209.5%+60.0%$393.69M$23.61M-3.6520Upcoming EarningsNews CoveragePositive NewsSNDLSNDL2.8848 of 5 stars$1.47-1.3%$3.63+146.6%-39.7%$386.28M$920.45M-4.74580ORKAOruka Therapeutics3.1837 of 5 stars$10.28+1.9%$39.86+287.7%N/A$384.89MN/A-1.64N/AAnalyst RevisionNews CoveragePositive NewsKMDAKamada3.8825 of 5 stars$6.64-0.7%$14.67+120.9%+23.9%$381.67M$160.95M23.71360Upcoming EarningsShort Interest ↓Positive NewsRVNCRevance Therapeutics2.46 of 5 stars$3.65flat$8.39+129.7%N/A$381.02M$234.04M-1.89500Upcoming EarningsTECXTectonic Therapeutic2.5591 of 5 stars$20.18-4.3%$72.40+258.8%N/A$376.62MN/A-3.43120Upcoming EarningsShort Interest ↑ Related Companies and Tools Related Companies PureTech Health Competitors Keros Therapeutics Competitors Erasca Competitors Sana Biotechnology Competitors Zevra Therapeutics Competitors SNDL Competitors Oruka Therapeutics Competitors Kamada Competitors Revance Therapeutics Competitors Tectonic Therapeutic Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:COYA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coya Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coya Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COYA Stock Free COYA Stock Alerts